Abstract 15134: Cardiovascular Consequences of Electrolyte Derangements in Tumor Lysis Syndrome: A Nationwide Cohort Study
Circulation · 02.11.2026 · 154 (Suppl_1)
DOI: 10.1161/circ.154.suppl_1.15134 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Circulation, erschienen am 02.11.2026. Verfasst von Aarjuv Majmundar und 5 weiteren Autor:innen.
Abstract (Originalsprache)
Introduction/Background Tumor lysis syndrome (TLS) is a life-threatening oncologic emergency characterized by rapid release of intracellular contents leading serum to hyperkalemia (HyperK), hyperphosphatemia (HyperP), hypocalcemia (HypoCa), and subsequent cardiovascular complications. Although electrolyte abnormalities are recognized triggers of malignant arrhythmias, the impact of specific electrolyte abnormality on arrhythmic risk and clinical outcomes in TLS remains poorly defined. Hypothesis We hypothesized that TLS patients with electrolyte abnormalities would experience higher rates of malignant arrhythmias, mortality, and healthcare utilization. Methods/Approach We performed a retrospective cohort study using the Nationwide Inpatient Sample (2016-2022). Adult hospitalizations with TLS were identified and categorized into 8 groups: None, HyperK, HyperP, HypoCa, HyperK+HyperP, HyperK+HypoCa, HyperP+HypoCa, and all 3 abnormalities. The primary outcome was malignant arrhythmia (ventricular tachycardia, ventricular fibrillation, cardiac arrest, or high-grade atrioventricular block). Secondary outcomes included inpatient mortality, length of stay, and total hospital charges. Survey-weighted multivariable regression adjusted for age, sex, and Elixhauser comorbidity score. Results/Data A weighted estimate of 100,880 TLS hospitalizations was identified. Hyperkalemia alone was the most common electrolyte abnormality (16.8%). Patients with electrolyte disturbances had significantly higher comorbidity burdens than those without. Malignant arrhythmias occurred in 5.4% of patients without electrolyte abnormalities, compared with 7.9% in HyperK, 9.0% in HyperK+HyperP, and 11.0% in HyperK+HypoCa (p
Zitieren
APA
Majmundar, A., Desai, A., Singh, S. T., Cohen, B., Roma, N., & Durkin, M. (2026). Abstract 15134: Cardiovascular Consequences of Electrolyte Derangements in Tumor Lysis Syndrome: A Nationwide Cohort Study. Circulation, 154(Suppl_1). https://doi.org/10.1161/circ.154.suppl_1.15134
Vancouver
Majmundar A, Desai A, Singh ST, Cohen B, Roma N, Durkin M. Abstract 15134: Cardiovascular Consequences of Electrolyte Derangements in Tumor Lysis Syndrome: A Nationwide Cohort Study. Circulation. 2026;154(Suppl_1). doi:10.1161/circ.154.suppl_1.15134
BibTeX
@article{Majmundar2026,
author = {Majmundar, Aarjuv and Desai, Aarsh and Singh, Saran T and Cohen, Brett and Roma, Nicholas and Durkin, Michael},
title = {Abstract 15134: Cardiovascular Consequences of Electrolyte Derangements in Tumor Lysis Syndrome: A Nationwide Cohort Study},
journal = {Circulation},
year = {2026},
volume = {154},
number = {Suppl_1},
doi = {10.1161/circ.154.suppl_1.15134}
}
EUVIMED